These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 21334406)
1. Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations. Chen X; Lingala S; Khoobyari S; Nolta J; Zern MA; Wu J J Hepatol; 2011 Oct; 55(4):838-45. PubMed ID: 21334406 [TBL] [Abstract][Full Text] [Related]
2. Hedgehog signaling pathway affects the sensitivity of hepatoma cells to drug therapy through the ABCC1 transporter. Ding J; Zhou XT; Zou HY; Wu J Lab Invest; 2017 Jul; 97(7):819-832. PubMed ID: 28414325 [TBL] [Abstract][Full Text] [Related]
3. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Ma S; Chan KW; Lee TK; Tang KH; Wo JY; Zheng BJ; Guan XY Mol Cancer Res; 2008 Jul; 6(7):1146-53. PubMed ID: 18644979 [TBL] [Abstract][Full Text] [Related]
4. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells. Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525 [TBL] [Abstract][Full Text] [Related]
5. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188 [TBL] [Abstract][Full Text] [Related]
6. Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study. Na DC; Lee JE; Yoo JE; Oh BK; Choi GH; Park YN Exp Mol Pathol; 2011 Feb; 90(1):66-73. PubMed ID: 20969862 [TBL] [Abstract][Full Text] [Related]
7. Aberrant hedgehog signaling is responsible for the highly invasive behavior of a subpopulation of hepatoma cells. Fan YH; Ding J; Nguyen S; Liu XJ; Xu G; Zhou HY; Duan NN; Yang SM; Zern MA; Wu J Oncogene; 2016 Jan; 35(1):116-24. PubMed ID: 25772244 [TBL] [Abstract][Full Text] [Related]
8. Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy. Nishikawa S; Konno M; Hamabe A; Hasegawa S; Kano Y; Ohta K; Fukusumi T; Sakai D; Kudo T; Haraguchi N; Satoh T; Takiguchi S; Mori M; Doki Y; Ishii H Int J Oncol; 2013 Apr; 42(4):1437-42. PubMed ID: 23440340 [TBL] [Abstract][Full Text] [Related]
9. An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma. Li M; Zhang L; Ge C; Chen L; Fang T; Li H; Tian H; Liu J; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li J Oncotarget; 2015 Sep; 6(28):25149-60. PubMed ID: 26327240 [TBL] [Abstract][Full Text] [Related]
10. Hypoxia Accelerates Aggressiveness of Hepatocellular Carcinoma Cells Involving Oxidative Stress, Epithelial-Mesenchymal Transition and Non-Canonical Hedgehog Signaling. Liu Z; Tu K; Wang Y; Yao B; Li Q; Wang L; Dou C; Liu Q; Zheng X Cell Physiol Biochem; 2017; 44(5):1856-1868. PubMed ID: 29237157 [TBL] [Abstract][Full Text] [Related]
11. Cell-surface Vimentin: A mislocalized protein for isolating csVimentin(+) CD133(-) novel stem-like hepatocellular carcinoma cells expressing EMT markers. Mitra A; Satelli A; Xia X; Cutrera J; Mishra L; Li S Int J Cancer; 2015 Jul; 137(2):491-6. PubMed ID: 25487874 [TBL] [Abstract][Full Text] [Related]
12. NEDD9 may regulate hepatocellular carcinoma cell metastasis by promoting epithelial-mesenchymal-transition and stemness via repressing Smad7. Wang Z; Shen M; Lu P; Li X; Zhu S; Yue S Oncotarget; 2017 Jan; 8(1):1714-1724. PubMed ID: 27974675 [TBL] [Abstract][Full Text] [Related]
13. CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Ma S; Lee TK; Zheng BJ; Chan KW; Guan XY Oncogene; 2008 Mar; 27(12):1749-58. PubMed ID: 17891174 [TBL] [Abstract][Full Text] [Related]
14. Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib. Yamada T; Abei M; Danjoh I; Shirota R; Yamashita T; Hyodo I; Nakamura Y BMC Cancer; 2015 Apr; 15():260. PubMed ID: 25885470 [TBL] [Abstract][Full Text] [Related]
15. Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells. Dong J; Zhai B; Sun W; Hu F; Cheng H; Xu J PLoS One; 2017; 12(9):e0185088. PubMed ID: 28934275 [TBL] [Abstract][Full Text] [Related]
16. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Silva IA; Bai S; McLean K; Yang K; Griffith K; Thomas D; Ginestier C; Johnston C; Kueck A; Reynolds RK; Wicha MS; Buckanovich RJ Cancer Res; 2011 Jun; 71(11):3991-4001. PubMed ID: 21498635 [TBL] [Abstract][Full Text] [Related]
17. CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer. Chen YS; Wu MJ; Huang CY; Lin SC; Chuang TH; Yu CC; Lo JF PLoS One; 2011; 6(11):e28053. PubMed ID: 22140506 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer. Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640 [TBL] [Abstract][Full Text] [Related]
19. CD133(+)EpCAM(+) phenotype possesses more characteristics of tumor initiating cells in hepatocellular carcinoma Huh7 cells. Chen Y; Yu D; Zhang H; He H; Zhang C; Zhao W; Shao RG Int J Biol Sci; 2012; 8(7):992-1004. PubMed ID: 22904667 [TBL] [Abstract][Full Text] [Related]
20. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells. Kryczek I; Liu S; Roh M; Vatan L; Szeliga W; Wei S; Banerjee M; Mao Y; Kotarski J; Wicha MS; Liu R; Zou W Int J Cancer; 2012 Jan; 130(1):29-39. PubMed ID: 21480217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]